520 BROAD STREET, NEWARK, NJ
July 2026 | Investor Presentation
Reports Third Quarter Fiscal 2026 Financial Results
Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C
Announces Patent Licensing Agreement with MIT for 'Small Molecules to Improve Myelination in ApoE4 Positive Alzheimer’s Disease'
Board Election Results from Rafael Holdings, Inc. Annual Meeting
Reports First Quarter Fiscal 2026 Financial Results
Other Events
Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
Q3
Q2
Q1
FY 2025
Amended Annual Report
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Certificate
Registration of Securities
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload